84 related articles for article (PubMed ID: 3089979)
1. Differences of host immune response and of sensitivity to chemotherapeutic agents between two clones of rat fibrosarcoma with different metastatic potential.
Futami H; Saijo N; Sasaki Y; Sakurai M; Nomori H; Takahashi H; Ishihara J; Hoshi A; Koyama K; Hamburger AW
Jpn J Cancer Res; 1986 May; 77(5):480-6. PubMed ID: 3089979
[TBL] [Abstract][Full Text] [Related]
2. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells.
Hollingsworth MA; Evans DL
J Natl Cancer Inst; 1984 Jun; 72(6):1357-63. PubMed ID: 6233443
[TBL] [Abstract][Full Text] [Related]
3. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
4. Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma.
Ferry BL; Flannery GR; Robins RA; Lawry J; Baldwin RW
Immunology; 1984 Oct; 53(2):243-50. PubMed ID: 6490084
[TBL] [Abstract][Full Text] [Related]
5. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
8. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced rat fibrosarcoma.
Nagashima A; Yasumoto K; Nakahashi H; Furukawa T; Inokuchi K; Nomoto K
Cancer Res; 1986 Sep; 46(9):4420-4. PubMed ID: 3731098
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of cancer metastasis].
Poupon MF; Becker M; Pauwels C; Moczar E; Korach S
Bull Cancer; 1984; 71(5):453-63. PubMed ID: 6395921
[TBL] [Abstract][Full Text] [Related]
11. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
[TBL] [Abstract][Full Text] [Related]
12. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
13. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
Aboud M; Kingsmore S; Segal S
Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
[TBL] [Abstract][Full Text] [Related]
14. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
[TBL] [Abstract][Full Text] [Related]
15. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats (author's transl)].
Itaya T
Hokkaido Igaku Zasshi; 1981 Sep; 56(5):499-506. PubMed ID: 7319460
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma.
Ren J; Hamada J; Takeichi N; Fujikawa S; Kobayashi H
Cancer Res; 1990 Jan; 50(2):358-62. PubMed ID: 2295075
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunosuppressive activity associated with metastatic lymphoma cells.
Hao W; McDonald TL; Brunson KW; Joshi SS
Cancer Res; 1993 Apr; 53(8):1921-8. PubMed ID: 8385575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
